Wed, Dec 4, 2024
[Archive]
Volume 5, Issue 3 (8-2015)
Iran J Ped Hematol Oncol 2015, 5(3): 145-148 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Valizadeh N, Noroozi M, Hejazi S, Nateghi S, Hashemi A. Seroprevalence of Hepatitis B, Hepatitis C and Human. Iran J Ped Hematol Oncol 2015; 5 (3) :145-148
URL: http://ijpho.ssu.ac.ir/article-1-215-en.html
URL: http://ijpho.ssu.ac.ir/article-1-215-en.html
Abstract: (3359 Views)
Abstract
Background
Thalassemia patients that are conventionally treated by a regular transfusion regimen are exposed to blood born viral infections.The aim of this study was to investigate the seroprevalence of hepatitis B virus (HBV), hepatitis C virus (HCV) , and human Immunodeficiency virus(HIV) among all multitransfused thalassemia patients in west north of Iran.
Material and methods
A retrospective study was conducted in February 2014, on 32 patients in Urmia, suffering from transfusion dependent thalassemia were admitted to Motahari and Emam Khomeini hospitals. Patients’ medical records were studied for HBs antigen and seropositivity for HCV, and HIV antibodies.
Results
Out of 32transfusion dependent thalassemia patients aged between 5-17years, 18 (56.25%) and14 (43.75%) were male and female, respectively. All of them were found seronegative for HBs antigen, HCV, and HIV antibodies.
Conclusion
It seems that screening of blood products is efficient in Urmia , capital of West Azarbaijan, Iran for prevention of blood born viral infections.
Type of Study: Research |
Subject:
Heart
Received: 2015/08/22 | Accepted: 2015/08/22 | Published: 2015/08/22
Received: 2015/08/22 | Accepted: 2015/08/22 | Published: 2015/08/22
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
